Clinical Research Directory
Browse clinical research sites, groups, and studies.
Prospective G7 Dual Mobility Total Hip PMCF
Sponsor: Zimmer Biomet
Summary
This is a prospective multi-center clinical evaluation following recipients of the G7 Dual Mobility hip device. The primary objective is to characterize survivorship of the G7 hip at five years post-index procedure. Secondary objectives include documentation of clinical outcomes, safety and radiographic data.
Official title: Prospective Multi-Center Clinical Evaluation Following Total Hip Arthroplasty With the G7 Dual Mobility System
Key Details
Gender
All
Age Range
18 Years - 80 Years
Study Type
OBSERVATIONAL
Enrollment
250
Start Date
2017-02-28
Completion Date
2029-02-28
Last Updated
2025-06-15
Healthy Volunteers
No
Interventions
G7 Dual Mobility hip
Total hip arthroplasty and implantation of the G7 device
Locations (6)
Jersey City Medical Center
Jersey City, New Jersey, United States
New Mexico Orthopaedics
Albuquerque, New Mexico, United States
University of North Carolina
Chapel Hill, North Carolina, United States
Oregon Health and Science University
Portland, Oregon, United States
Tidewater Orthopaedics
Hampton, Virginia, United States
Ortho Virginia
Richmond, Virginia, United States